Market research

IMRNW Immuron Ltd

NASDAQ USD Healthcare

Latest close

0.0732 —

As of 10 Jun 2022

Test a moving-average rule with historical data.

Market facts

Market cap: Not available
P/E ratio: Not available
Analyst target: Not available
Dividend yield: 0.0%
Beta: Not available

Loading price history…

Stored daily observations

Recent price history

Quote currency: USD. The close is unadjusted; adjusted close reflects stored price adjustments. These are historical observations, not live quotes.

Up to five recent stored daily observations for IMRNW.
Date	Close	Adjusted close
10 Jun 2022	0.0732	0.0732
09 Jun 2022	0.0711	0.0711
08 Jun 2022	0.09	0.09
07 Jun 2022	0.09	0.09
06 Jun 2022	0.16	0.16

Stored daily observations begin 09 Jun 2017. This summary does not establish continuous or point-in-time-qualified coverage. Backtests validate their own required dates, sources and eligibility.

Browse US Stock instruments · Read the no-code backtesting walkthrough

Profile

Instrument facts

Exchange: NASDAQ
Currency: USD
Sector: Healthcare
Industry: Biotechnology
ISIN: Not available
Market cap: Not available
P/E ratio: Not available
Analyst target: Not available
Dividend yield: 0.0%
Beta: Not available
MarketCapitalization: Not available

About

About Immuron Ltd

A company description is not available for this instrument.

Research context

Immuron Ltd appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.

Currency: USD
Sector: Healthcare
Industry: Biotechnology

These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.

Review backtest assumptions and evidence before treating a chart or stored history as a research result.

Fundamentals are not available

This instrument does not currently have reported company financials in PyInvesting.

Admin

5 years, 7 months ago

IMRNW is currently in a long term downtrend where the price is trading 13.0% below its 200 day moving average.

From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Other sector with a price to sales ratio of 0.0.

Based on the above factors, IMRNW gets an overall score of 1/5.